Clinical significance of machine learning algorithm in predicting PPM during TAVR in small annuli
Yu Mao1, Yang Liu1, Mengen Zhai1
1Department of Cardiovascular Surgery, Xijing Hospital, 127 Changle West Road, Xi'an, 710032, Shaanxi, China.
Cardiovascular Intervention and Therapeutics
|January 6, 2026
Summary
Echocardiography overestimates aortic valve gradients in small annuli during TAVR. An XGBoost model improved accuracy, showing higher predicted gradients correlate with worse patient prognosis.
Area of Science:
- Cardiology
- Medical Imaging
- Artificial Intelligence in Medicine
Background:
- Accurate measurement of aortic valve pressure gradient (PG_AV) is crucial for transcatheter aortic valve replacement (TAVR) outcomes.
- Echocardiography often overestimates PG_AV in patients with small aortic annuli compared to left heart catheterization (LHC).
Purpose of the Study:
- To enhance the accuracy of PG_AV measurements using echocardiography in small annuli during TAVR.
- To assess the prognostic impact of accurately measured PG_AV on patient outcomes.
Main Methods:
- Trained an extreme gradient boosting (XGBoost) algorithm on data from 273 patients with aortic stenosis and small annuli undergoing TAVR.
- Compared PG_AV measurements from transthoracic echocardiography (TTE) with LHC data.
- Evaluated the association between predicted PG_AV and a composite endpoint of mortality and heart failure readmission.
Main Results:
- Baseline TTE measurements of PG_AV were significantly overestimated compared to LHC (52.5 mmHg vs. 42.5 mmHg, P < 0.001).
- The XGBoost model significantly improved TTE PG_AV accuracy (Pearson correlation coefficient = 0.94, P < 0.001).
- Patients with a predicted mean PG_AV ≥ 68.6 mmHg had a substantially higher incidence of composite endpoints at 2 years (40.7% vs. 16.0%, P < 0.001).
Conclusions:
- The XGBoost model effectively improves the accuracy of echocardiographic PG_AV measurements during TAVR in small annuli.
- An elevated predicted PG_AV, accurately measured, is associated with a worse prognosis in TAVR patients.
- Improved PG_AV measurement accuracy can aid in better patient selection and risk stratification for TAVR.


